1. Home
  2. CRESY vs KROS Comparison

CRESY vs KROS Comparison

Compare CRESY & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

HOLD

Current Price

$11.79

Market Cap

718.2M

Sector

Finance

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.37

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRESY
KROS
Founded
1936
2015
Country
Argentina
United States
Employees
2889
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
718.2M
584.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CRESY
KROS
Price
$11.79
$11.37
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$21.86
AVG Volume (30 Days)
254.0K
321.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
8.14%
N/A
EPS Growth
N/A
146.00
EPS
N/A
N/A
Revenue
N/A
$243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,751.79
P/E Ratio
$6.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.39
$9.79
52 Week High
$14.21
$22.55

Technical Indicators

Market Signals
Indicator
CRESY
KROS
Relative Strength Index (RSI) 59.51 50.53
Support Level $11.12 $10.47
Resistance Level $12.25 $12.43
Average True Range (ATR) 0.42 0.69
MACD 0.11 0.04
Stochastic Oscillator 96.09 65.08

Price Performance

Historical Comparison
CRESY
KROS

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: